What did the Medical Device User Fees Amendment of 2012 authorize the FDA to do?

What did the Medical Device User Fees Amendment of 2012 authorize the FDA to do?

• A. Extend deadlines
• B. Dismiss safety reviews
• C. Ban certain devices
• D. Collect user fees for pre-market approvals to improve the overall review process

Answer: (D)

This amendment centers on funding the device review process. It authorizes the FDA to collect user fees from manufacturers to support the premarket review of medical devices, with the goal of speeding up and making reviews more predictable. The fees provide resources for FDA reviewers, help meet defined performance timelines, and improve overall efficiency of evaluating submissions like PMAs, PMA supplements, 510(k) submissions, and De Novo requests, all while maintaining safety standards. It’s not about extending deadlines, dismissing safety reviews, or banning devices—it's about funding and structuring the review process to be faster and more consistent.

This amendment centers on funding the device review process. It authorizes the FDA to collect user fees from manufacturers to support the premarket review of medical devices, with the goal of speeding up and making reviews more predictable. The fees provide resources for FDA reviewers, help meet defined performance timelines, and improve overall efficiency of evaluating submissions like PMAs, PMA supplements, 510(k) submissions, and De Novo requests, all while maintaining safety standards. It’s not about extending deadlines, dismissing safety reviews, or banning devices—it's about funding and structuring the review process to be faster and more consistent.